We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    FSQ02
Previous Study | Return to List | Next Study

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04210349
Recruitment Status : Completed
First Posted : December 24, 2019
Last Update Posted : November 9, 2022
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )